[The treatment of bronchial asthma with powdered salbutamol and powdered beclomethasone dipropionate].
The active bronchodilators and anti-inflammatory drugs used as dry powder in inhalatory treatment of bronchial asthma represent an important advance during last years. In this way the inconveniences of pressurized aerosols treatment where the drugs are only partially inhaled as well as severe side-effects of systemic corticotherapy are avoided. The bronchodilator drug Ventodisk and the antiinflammatory Becodisks as dry powder are given by inhalation with a special device (Diskhaler). The study deals with a group of 60 subjects with moderate and severe forms of bronchial asthma out of which 20 were treated by Ventodisk associated to Becodisks and other two groups of 20 subjects each treated during the same interval time with only Becodisks and Ventodisk respectively. The clinical results after two months treatment were much better in the first group of subjects (85% good results) in comparison to Becodisks (75%) and Ventodisk (60%) treated cases. One can state in conclusion that the association of Ventodisk to Becodisks leads to very good results in basic treatment of bronchial asthma.